Morgan Stanley
PPH icon

Morgan Stanley’s VanEck Pharmaceutical ETF PPH Stock Holding History

Morgan Stanley’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5M Sell
177,847
-99,759
-36% -$10.6M ﹤0.01% 3028
2025
Q4 		$28.6M Sell
277,606
-377,981
-58% -$36.8M ﹤0.01% 2608
2025
Q3 		$59.2M Buy
655,587
+117,189
+22% +$10.3M ﹤0.01% 1877
2025
Q2 		$47.4M Buy
538,398
+446,997
+489% +$38.7M ﹤0.01% 1981
2025
Q1 		$8.33M Sell
91,401
-10,469
-10% -$943K ﹤0.01% 3510
2024
Q4 		$8.79M Buy
101,870
+18,327
+22% +$1.66M ﹤0.01% 3515
2024
Q3 		$7.94M Buy
83,543
+3,483
+4% +$331K ﹤0.01% 3612
2024
Q2 		$7.32M Sell
80,060
-24,577
-23% -$2.19M ﹤0.01% 3577
2024
Q1 		$9.49M Sell
104,637
-73,219
-41% -$6.41M ﹤0.01% 3390
2023
Q4 		$14.5M Buy
177,856
+82,074
+86% +$6.44M ﹤0.01% 3621
2023
Q3 		$7.65M Buy
95,782
+29,067
+44% +$2.34M ﹤0.01% 3364
2023
Q2 		$5.26M Sell
66,715
-35,572
-35% -$2.78M ﹤0.01% 3738
2023
Q1 		$7.94M Sell
102,287
-18,339
-15% -$1.41M ﹤0.01% 3362
2022
Q4 		$9.38M Buy
120,626
+14,621
+14% +$1.08M ﹤0.01% 3154
2022
Q3 		$7.13M Sell
106,005
-83,234
-44% -$6.13M ﹤0.01% 3325
2022
Q2 		$14.5M Buy
189,239
+147,769
+356% +$11.5M ﹤0.01% 2639
2022
Q1 		$3.31M Buy
41,470
+301
+0.7% +$23K ﹤0.01% 4108
2021
Q4 		$3.17M Sell
41,169
-18,646
-31% -$1.39M ﹤0.01% 4193
2021
Q3 		$4.36M Buy
59,815
+2,147
+4% +$160K ﹤0.01% 3886
2021
Q2 		$4.21M Buy
57,668
+24,761
+75% +$1.77M ﹤0.01% 3959
2021
Q1 		$2.27M Sell
32,907
-2,808
-8% -$193K ﹤0.01% 4157
2020
Q4 		$2.37M Sell
35,715
-2,531
-7% -$162K ﹤0.01% 4007
2020
Q3 		$2.38M Buy
38,246
+9,265
+32% +$586K ﹤0.01% 3503
2020
Q2 		$1.8M Buy
28,981
+1,491
+5% +$90.2K ﹤0.01% 3685
2020
Q1 		$1.5M Sell
27,490
-6,333
-19% -$390K ﹤0.01% 3618
2019
Q4 		$2.17M Buy
33,823
+9,159
+37% +$552K ﹤0.01% 3970
2019
Q3 		$1.41M Buy
24,664
+951
+4% +$54.5K ﹤0.01% 4075
2019
Q2 		$1.39M Sell
23,713
-1,382
-6% -$80K ﹤0.01% 4032
2019
Q1 		$1.52M Sell
25,095
-802
-3% -$47.4K ﹤0.01% 3815
2018
Q4 		$1.42M Sell
25,897
-3,928
-13% -$238K ﹤0.01% 4035
2018
Q3 		$1.92M Sell
29,825
-31,895
-52% -$1.99M ﹤0.01% 4038
2018
Q2 		$3.64M Buy
61,720
+305
+0.5% +$17.7K ﹤0.01% 3524
2018
Q1 		$3.49M Sell
61,415
-30,305
-33% -$1.81M ﹤0.01% 3435
2017
Q4 		$5.44M Buy
91,720
+21,526
+31% +$1.23M ﹤0.01% 3025
2017
Q3 		$4.05M Sell
70,194
-9,189
-12% -$522K ﹤0.01% 3190
2017
Q2 		$4.69M Sell
79,383
-11,348
-13% -$642K ﹤0.01% 2913
2017
Q1 		$5M Sell
90,731
-4,966
-5% -$269K ﹤0.01% 2865
2016
Q4 		$5.03M Buy
95,697
+27,320
+40% +$1.46M ﹤0.01% 2985
2016
Q3 		$3.93M Sell
68,377
-113,869
-62% -$6.83M ﹤0.01% 2905
2016
Q2 		$10.7M Sell
182,246
-142,802
-44% -$8.32M ﹤0.01% 1930
2016
Q1 		$18.7M Sell
325,048
-21,954
-6% -$1.3M 0.01% 1351
2015
Q4 		$22.7M Sell
347,002
-86,578
-20% -$5.59M 0.01% 1306
2015
Q3 		$27.3M Sell
433,580
-38,672
-8% -$2.72M 0.01% 1154
2015
Q2 		$33.4M Buy
472,252
+350,517
+288% +$25.2M 0.01% 1108
2015
Q1 		$8.55M Buy
121,735
+28,191
+30% +$1.91M ﹤0.01% 2229
2014
Q4 		$6.01M Buy
93,544
+4,455
+5% +$284K ﹤0.01% 2548
2014
Q3 		$5.66M Sell
89,089
-8,610
-9% -$533K ﹤0.01% 2543
2014
Q2 		$6.06M Buy
97,699
+2,386
+3% +$142K ﹤0.01% 2489
2014
Q1 		$5.56M Sell
95,313
-100
-0.1% -$5.66K ﹤0.01% 2492
2013
Q4 		$5.07M Sell
95,413
-2,799
-3% -$142K ﹤0.01% 2552
2013
Q3 		$4.7M Sell
98,212
-11,220
-10% -$532K ﹤0.01% 2482
2013
Q2 		$4.98M Buy
+109,432
New +$5.06M ﹤0.01% 2330

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Morgan Stanley's PPH Position: Q1 2026 in Review

Morgan Stanley reduced its VanEck Pharmaceutical ETF (PPH) stake by 36% in Q1 2026, selling an estimated $10.6M and leaving 177,847 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3028.

Morgan Stanley first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $59.2M in Q3 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Morgan Stanley held 177,847 shares of VanEck Pharmaceutical ETF worth $18.5M as of Q1 2026.
  • Morgan Stanley sold 99,759 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $10.6M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3028 holding.
  • Morgan Stanley first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's VanEck Pharmaceutical ETF position peaked at $59.2M in Q3 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.